Learn How to Work with CDC and other federal agencies at the BIO Convention

Discover the research priorities, biotechnology capacity and collaborative needs for the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes for Health (NIH) and the Food and Drug Administration (FDA). Learn how to partner with federal scientists to access hot technologies for licensure. Gain insight into FDA's regulatory science and perspective with emphasis on nanotechnology, genomics, rapid detection and regenerative medicine. Additional topical sessions will highlight the Federal Laboratory Consortium, Biomedical High Performance Computing and Emergency Use Authorization for expedited authorization of unapproved biomedical products and devices during public health emergencies.

The CDC has organized six informative sessions under the title, Federal Science and Opportunities, Tuesday, May 19, at the Georgia World Congress Center. Concurrent sessions will be held in the morning (8:00 am – 9:30 am, 10:00 am – 11:30 am) and in the afternoon (2 pm to 3:30 pm).

The sessions are:

• How to Partner with Government - Tuesday, May 19: 8:00 AM - 9:30 AM
• Regulatory Science and Perspectives: Scientific Priorities at FDA - Tuesday, May 19: 8:00 AM - 9:30 AM
• Hot Federal Biotechnologies Available for Collaboration - Tuesday, May 19: 10:00 AM - 11:30 AM
• Use of Products during Public Health Crisis: Focus on Emergency Use Authorization (EUA) - Tuesday, May 19: 10:00 AM - 11:30 AM
• Federal Labortory Consortium - Tuesday, May 19: 2:00 PM - 3:30 PM
• Biomedical Computing and Improved Health Care - Tuesday, May 19: 2:00 PM - 3:30 PM

Learn more about the CDC Sessions